Variant report
Variant | esv3452685 |
---|---|
Chromosome Location | chr1:212080253-212081356 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-INTS7-2 | chr1:212080694-212080795 | NONHSAT009337 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186757109 | chr1:212080265-212080266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545393743 | chr1:212080343-212080344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17018161 | chr1:212080347-212080348 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs12045599 | chr1:212080363-212080364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574581294 | chr1:212080459-212080460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543496966 | chr1:212080470-212080471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542852364 | chr1:212080491-212080492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560632553 | chr1:212080524-212080525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528199960 | chr1:212080545-212080546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs202070454 | chr1:212080627-212080628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546160290 | chr1:212080628-212080629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143392634 | chr1:212080651-212080652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368404761 | chr1:212080690-212080691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12565502 | chr1:212080691-212080692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2970583 | chr1:212080703-212080704 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs76624264 | chr1:212080711-212080712 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs55685367 | chr1:212080712-212080713 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs145040457 | chr1:212080714-212080715 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs532392143 | chr1:212080754-212080755 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs116127918 | chr1:212080776-212080777 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs376694250 | chr1:212080800-212080801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2970582 | chr1:212080831-212080832 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs115677870 | chr1:212080861-212080862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372140115 | chr1:212080917-212080918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs80291499 | chr1:212080954-212080955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567744305 | chr1:212080977-212080978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75692241 | chr1:212081011-212081012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553369049 | chr1:212081035-212081036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76418769 | chr1:212081059-212081060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374568791 | chr1:212081071-212081072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545636757 | chr1:212081079-212081080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs193008053 | chr1:212081102-212081103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184663295 | chr1:212081141-212081142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542790782 | chr1:212081156-212081157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190383051 | chr1:212081177-212081178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs151258792 | chr1:212081199-212081200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17018162 | chr1:212081213-212081214 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs371918490 | chr1:212081265-212081266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35247998 | chr1:212081289-212081290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Macular degeneration | 22558131 | CNVD |
Alzheimer''s disease | 21403675 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 17060936 | CNVD |
Atypical hemolytic uremic syndrome | 19861685 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:212076200-212080800 | Weak transcription | Esophagus | oesophagus |
2 | chr1:212076200-212083600 | Weak transcription | Pancreas | Pancrea |
3 | chr1:212077200-212082600 | Weak transcription | Colonic Mucosa | Colon |
4 | chr1:212077400-212082400 | Weak transcription | Adipose Nuclei | Adipose |
5 | chr1:212078000-212082400 | Weak transcription | Duodenum Mucosa | Duodenum |
6 | chr1:212078000-212082400 | Weak transcription | HepG2 | liver |
7 | chr1:212078400-212081800 | Weak transcription | Liver | Liver |
8 | chr1:212078800-212080400 | Weak transcription | Fetal Intestine Large | intestine |
9 | chr1:212078800-212080800 | Weak transcription | Fetal Intestine Small | intestine |
10 | chr1:212079600-212087400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr1:212080000-212081000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
12 | chr1:212080400-212087600 | Enhancers | Fetal Intestine Large | intestine |
13 | chr1:212080800-212081000 | Enhancers | Esophagus | oesophagus |
14 | chr1:212080800-212081400 | Enhancers | GM12878-XiMat | blood |
15 | chr1:212080800-212087000 | Enhancers | Fetal Intestine Small | intestine |
16 | chr1:212081000-212085000 | Enhancers | Primary monocytes fromperipheralblood | blood |
17 | chr1:212081200-212082200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
18 | chr1:212081200-212083600 | Weak transcription | Esophagus | oesophagus |